Related references
Note: Only part of the references are listed.The effect of pathophysiology on pharmacokinetics in the critically ill patient - Concepts appraised by the example of antimicrobial agents
Stijn I. Blot et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Pharmacokinetics of caspofungin in ICU patients
E. W. Muilwijk et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Population Pharmacokinetics of Escalating Doses of Caspofungin in a Phase II Study of Patients with Invasive Aspergillosis
Gudrun Wuerthwein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Weight Drives Caspofungin Pharmacokinetic Variability in Overweight and Obese People: Fractal Power Signatures beyond Two-Thirds or Three-Fourths
Ronald G. Hall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Body Mass Index Is Associated With Hospital Mortality in Critically Ill Patients: An Observational Cohort Study
Peter Pickkers et al.
CRITICAL CARE MEDICINE (2013)
A Pharmacokinetic Standard for Babies and Adults
Nick Holford et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Population Pharmacokinetics of Liposomal Amphotericin B and Caspofungin in Allogeneic Hematopoietic Stem Cell Recipients
Gudrun Wuerthwein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
David R. Andes et al.
CLINICAL INFECTIOUS DISEASES (2012)
Fractal Geometry and the Pharmacometrics of Micafungin in Overweight, Obese, and Extremely Obese People
Ronald G. Hall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis
O. A. Cornely et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Pirana and PCluster: A modeling environment and cluster infrastructure for NONMEM
Ron J. Keizer et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2011)
Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
M. A. Pfaller et al.
DRUG RESISTANCE UPDATES (2011)
In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species
D. Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Echinocandin pharmacodynamics: review and clinical implications
Melanie W. Pound et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida spp.
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
A Multicenter, Double-Blind Trial of a High-Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis
Robert F. Betts et al.
CLINICAL INFECTIOUS DISEASES (2009)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Mechanistic Basis of Using Body Size and Maturation to Predict Clearance in Humans
Brian J. Anderson et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C-glabrata in a neutropenic murine candidiasis model
D. R. Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing
William W. Hope et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Single- and multiple-dose administration of caspofungin in patients with hepatic insufficiency: Implications for safety and dosing recommendations
Goutom C. Mistry et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation
A. Safdar et al.
BONE MARROW TRANSPLANTATION (2007)
Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: Importance of persistence of caspofungin in tissues to understanding drug activity
A Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
PsN-Toolkit - A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM
L Lindbom et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2005)
Quantification of lean bodyweight
S Janmahasatian et al.
CLINICAL PHARMACOKINETICS (2005)
Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: Evidence of concentration-dependent activity
NP Wiederhold et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Comparison of caspofungin and amphotericin B for invasive candidiasis.
J Mora-Duarte et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
